Breaking News

EFPIA Calls for Greater Clarity Around the Regulatory Role of Digital Health Technology

Digital health technologies (DHT), including digital medication adherence monitoring, have the potential to revolutionize drug development, and must be given every opportunity to succeed.  That’s according to the European Federation of Pharmaceutical Industries and Associations (EFPIA) reflection paper, which has called for greater clarity and harmonization around how digital solutions fit into the regulatory pathway.…

Read More

How AARDEX Group’s Medication Adherence Technology Helped Iroko Gain FDA Approval

Proving the efficacy of investigational products is a complex process but with the right Medication Adherence Technology, sponsors can generate the evidence that they need to get drugs from labs to life, faster. Unmet Medical Need Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to combat pain, reduce inflammation, and reduce high temperatures.…

Read More

Pfizer Acknowledges the Need for Better Medication Adherence in Clinical Trials

medication adherence in clinical trials

Drug giant, Pfizer has highlighted the need for effective, patient-centered medication adherence management in clinical trials. Nothing stops a drug from working more than not taking it, but, as medicine and leadership pioneer and Pfizer’s Chief Medical Officer, said, non-adherence in clinical trials damages more than the patient.  “It is also corrosive to the integrity…

Read More

AARDEX Group and BIOCORP Recruited by [email protected] – Decentralized Trial Centre of Excellence

Trials@Home Press Release

Combining BIOCORP’s pen injector add-on with AARDEX® Group’s Software to improve adherence to medication in a Hybrid Phase IV Diabetes Study. Liege, Belgium – July 19, 2022: Following the launch of their global collaboration to support medication adherence in different fields last year, Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in…

Read More

ESPACOMP Backs Electronic Medication Monitoring as “Method of Choice” for Quantifying Medication Adherence in Clinical Trials

electronic medication monitoring

Effectively measuring medication adherence relies on selecting the most appropriate data source – and for clinical trials, that data source is electronic medication monitoring. The TEOS (timelines-events-objectives-source) guideline provides a clear framework on how to assess medicine-taking behavior relative to the scenario, and a new review paper makes clear that electronic medication monitoring is the…

Read More

Smart Caps Improve Medication Adherence in Clinical Trials – It’s a Fact!

Smart Cap

Poor medication adherence is a problem that has gone “unsolved” for decades. But combining smart caps with individualized feedback can drive the adherence that proves the investigational product efficacy and underwrites approvals. In this case study, we set out the crucial role of medication adherence in clinical research and explain how using AARDEX® Group’s Smart Cap,…

Read More

High Fidelity Measurement of Patients’ Medication Adherence: A Missing Link in Precision Medicine

Precision Medicine

The emergence of pharmacogenomics is an important milestone in the precision medicine journey – but the importance of measuring medicine adherence, an essential component in the complex pharmacokinetics/ pharmacodynamics equation, can often be overlooked. In this article, Bernard Vrijens, CEO and Scientific Lead at AARDEX Group, argues that the industry must use every tool in…

Read More

Clincal Trials and Tribulations Newsletter – May 2022 Edition

Clinical Trials and Tribulations Newsletter - May 2022

Welcome to the May edition of AARDEX Group’s Clinical Trials and Tribulations Newsletter – an aggregated collective of all of the industry’s hottest news and views!  Breaking News New Pivotal Data Demonstrates the Clinical Benefit of Roche’s glofitamab, a Potential First-in-Class Bispecific Antibody for People with Aggressive Lymphoma Roche today announced that new pivotal data…

Read More